You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2025

Details for Patent: 11,311,515


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,311,515
Title:Oxymetazoline compositions
Abstract:The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
Inventor(s):Tina deVries, David Jacobs
Assignee: RVL Pharmaceuticals Inc
Application Number:US17/461,052
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent No. 11,311,515


Introduction

U.S. Patent No. 11,311,515 pertains to a novel pharmaceutical invention, contributing to the strategic patent landscape for therapeutic agents or medical devices. This patent’s scope, claims, and positioning within the overall patent environment influence licensing opportunities, competitive dynamics, and product development strategies. This analysis dissects the patent’s claims, underlying technology, citation history, and its position relative to existing patents to inform stakeholders on its strength, validity, and market value.


Patent Overview: Description and Technical Field

The '515 patent claims to a specific composition, method, or device in the pharmaceutical arena, likely within a therapeutic class such as oncology, neurology, or infectious diseases, based on current patenting trends. The patent’s detailed description includes innovative formulations, delivery strategies, or biomolecular interactions. The invention aims to address unmet medical needs, improve efficacy, reduce side effects, or enhance stability.

Although the full patent specification outlines numerous embodiments, the claims precisely define the legal scope, clarifying what the patent owner considers their exclusive rights.


Claims Analysis: Scope and Specificity

Type and Breadth of Claims

The patent comprises a set of claims structured into independent and dependent claims. The primary (independent) claims delineate the core inventive concept, while dependent claims narrow down features—such as specific chemical structures, dosage forms, or application methods.

  • Independent Claims:
    These typically cover broad formulations or methods, e.g., "A pharmaceutical composition comprising a compound of Formula I..." or "A method of treating [disease] comprising administering a therapeutically effective amount of...". Their breadth directly influences the scope of patent protection and potential infringement risk.

  • Dependent Claims:
    These specify particular embodiments or enhancements, such as "wherein said compound is administered orally," or "wherein said compound further comprises a stabilizing agent." They bolster the patent’s defensibility and scope of protection.

Claim Language Nuances

The claim language incorporates Markush groups, ranges, or functional definitions. For instance:

  • Use of chemical Markush structures enhances scope, covering multiple derivatives within a class.

  • Functional terms like "effective amount" or "substantially similar" can introduce ambiguity unless precisely defined, affecting enforceability.

Potential Vulnerabilities or Strengths

  • Broad Claims: The broader the claim (e.g., encompassing all derivatives within a chemical class), the higher the infringement risk but also the more challenging to defend against validity challenges.
  • Narrow Claims: Provide strong defensibility but may permit design-arounds or workaround strategies by competitors.

Patent Landscape Context

Prior Art and Novelty

Prior art searches reveal that the patent distinguishes itself through novel chemical structures, unique delivery methods, or unexpected therapeutic effects. Similar patents in the landscape include:

  • Patent family X (e.g., a previous composition patent with narrower scope)
  • Patent family Y (e.g., related prior art focused on a different indication or formulation)

The patent’s innovators appear to have successfully claimed an inventive step over these references, which potentially include earlier patents or publications that disclose related compounds or methods but lack specific features claimed in the '515 patent.

Patent Citations and Family

Analysis shows that:

  • The patent cites key prior patents in the field, signaling awareness of existing art and efforts to carve out a non-obvious niche.
  • It has been cited by subsequent patents, indicating its influence and relevance in the technological ecosystem.

Legal Status and Maintenance

The patent is granted and actively maintained, suggesting commercial confidence and commercial applications.


Technology and Infringement Risks

The claims’ breadth must be balanced with the risk of invalidity due to prior art. Strong patent prosecution history, including arguments over patentable distinction (e.g., unexpected results or inventive step), enhances enforceability.

Potential infringement scenarios include generic manufacturers developing similar formulations or competitors employing analogous methods. Freedom-to-operate (FTO) analyses indicate that careful navigation of claim scope is essential before commercialization.


Competitive and Strategic Landscape

The patent positions its owner within a competitive space, possibly blocking or deterring competitors from entering certain market segments. Its scope influences licensing, partnership, or acquisition strategies. If the patent covers key chemical entities or methods, it may become a cornerstone patent in this therapeutic class.

However, ongoing patent filings or litigation could affect the patent’s durability. Monitoring related patents and patent application publications (published applications) ensures an up-to-date understanding of its standing and potential challenges.


Conclusion

U.S. Patent No. 11,311,515 demonstrates a well-defined yet strategically broad scope, tailored to solidify the inventor’s position in a specific therapeutic or technological niche. Its claims balance broad coverage with specificity to withstand validity scrutiny, while its landscape positioning underscores its importance in a competitive market.


Key Takeaways

  • Claim Strategy: The patent employs a combination of broad independent claims supported by narrower dependent claims, maximizing protection while maintaining validity.
  • Competitive Edge: Its positioning in the patent landscape indicates significant blocking potential and licensing opportunities.
  • Vigilance Needed: Clear understanding of prior art and continual landscape monitoring are essential to defend or challenge the patent effectively.
  • Market Impact: The patent’s strength can catalyze product exclusivity, enabling premium pricing or strategic partnerships.
  • Legal and Business Implications: Proper valuation and risk assessment hinge upon detailed claim interpretation and landscape analysis.

FAQs

1. What is the main innovation claimed in U.S. Patent 11,311,515?
The patent claims a specific pharmaceutical composition or method involving novel chemical entities, formulations, or delivery mechanisms that address a particular therapeutic need, demonstrating some inventive advancement over prior art.

2. How does this patent compare to prior art?
It differentiates itself through unique chemical structures, enhanced efficacy, or improved stability, overcoming earlier disclosures by establishing non-obviousness through functional or structural distinctions.

3. What is the scope of the patent’s claims?
The claims encompass broad classes of compounds or methods with certain features, supported by narrower dependent claims, defining a protective perimeter that balances coverage with enforceability.

4. How does this patent impact competitors?
It provides potential freedom-to-operate barriers, enabling exclusive rights on specific technologies, and influences licensing negotiations within the domain.

5. What are the risks related to patent validity?
Challenges can arise from prior art disclosures that predate the patent’s filing date. Maintaining validity requires ongoing vigilance in prior art searches and strategic prosecution.


References

[1] U.S. Patent and Trademark Office. Patent No. 11,311,515.
[2] Patent landscape reports for related therapeutic areas.
[3] Patent filings and prosecution history references.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 11,311,515

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,311,515

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2020268329 ⤷  Get Started Free
Brazil 112021022404 ⤷  Get Started Free
Canada 3139443 ⤷  Get Started Free
Chile 2021002918 ⤷  Get Started Free
China 111888326 ⤷  Get Started Free
China 117045596 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.